PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Widely prescribed MS treatment may not slow progression of disease: VCH-UBC research

2012-07-18
(Press-News.org) Researchers with the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and the University of British Columbia have published important data in the Journal of the American Medical Association (JAMA) about the impact of a common drug therapy on the progression of multiple sclerosis for people with the relapsing‑remitting form of the disease.

The study, led by Drs. Helen Tremlett, Afsaneh Shirani, Joel Oger and others, shows no strong evidence that a group of drugs, beta interferons (β-IFNs), prescribed to treat MS had a measurable impact on the long-term disability progression of the disease.

The team examined the linked health records of 2656 BC patients between 1985 - 2008 in a retrospective cohort study, which means data from already collected sources were linked together in an anonymized form and studied. Data sources included the BC Ministry of Health, PharmaNet and the BC Multiple Sclerosis (BCMS) database, facilitated by Population Data BC.

The study population included patients with MS who were treated with beta interferons (β-IFNs), the most widely used treatment for relapsing‑remitting MS, as well as untreated MS patients. The research team discovered that administration of β-IFN was not associated with a significant change in the progression of disability.

These findings will be of interest to MS patients with this form of the disease, but researchers are quick to point out that this is just one measure of these disease modifying drugs and there is still potentially significant benefit to patients.

"What this study provides is additional information to patients and clinicians about the longer term effect of this class of drugs," says corresponding author, Dr. Helen Tremlett (PhD), who also holds the Canada Research Chair in Neuroepidemiology and Multiple Sclerosis at UBC. "We know that this class of drugs is very helpful in reducing relapses, which can be important to patients. We do not recommend that patients stop taking these medications, but these findings provide evidence, allowing more realistic expectations as to the anticipated benefits associated with drug treatment from the disability perspective."

"It is still possible that some patients gain long-term benefit from β-IFNs. We are currently working toward identifying who those potential treatment responders might be," says Dr Afsaneh Shirani, who is the first author of the paper and a post-doctoral research fellow in the UBC Faculty of Medicine and Brain Research Centre at UBC and VCH Research Institute. "Our study also encourages the investigation of novel treatments for MS," she adds.

"In addition, this study suggests that linked data from health administrative databases have enormous potential for research applications, despite all the challenges of record linkage" says Dr Shirani.

Relapsing-remitting MS is characterized by relapses or "flare-ups" during which time new symptoms can appear or old ones can resurface or worsen. The relapses are followed by periods of remission during which time the person can fully or partially recover. Relapsing-remitting MS is the most common form of MS affecting around 85% of MS patients in Canada.

"In clinical trial situations, it has been quite evident for years that patients receiving β-IFN treatment have reduced frequency of relapses as well as reduced frequency of new lesions seen on MRI," says Dr. Joel Oger, who is also a neurologist with the UBC Hospital MS Clinic. "This study following a large number of patients for a long time in "real life situation" does not show an association of the β-IFNs with long term disability and tends to confirm a more modern way of understanding MS: relapses may not be responsible for long term disability in all patients and another mechanism might be at work as well."

The research team is preparing for future studies further examining this and other classes of disease modifying drugs. The hope is that the research will ultimately lead to an individualized approach to the treatment of MS.

### The team of ten researchers and doctors at the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and Department of Statistics, UBC are considered global leaders in the research and treatment of this disease. The clinic includes one of the largest MS databases in the world, and research themes span from pharmaceutical treatments to CCSVI, epidemiology, neuroimmunology, imaging, genetics, rehabilitation, and quality of life.

Partners in Research This study was funded jointly by the Canadian Institutes of Health Research and the US National MS Society. The researchers are also funded by the MS Society of Canada, the Michael Smith Foundation for Health Research, the Canada Research Chair program, the Natural Sciences and Engineering Research Council of Canada and the Christopher Foundation of Vancouver.


ELSE PRESS RELEASES FROM THIS DATE:

New video series highlights the people who fuel America's innovation pipeline

2012-07-18
The researchers reflect on their work as well as how the U.S. system for funding research makes the United States a leader. "Because of the opportunities provided by federal research funding, we are developing a generation of scientists that has no competitor on planet Earth," says Erik Dutson, executive medical director of the Center for Advanced Surgical and Interventional Technology at the University of California, Los Angeles. They also talk about the risks of decreased funding. "If you have a population of scientists that [don't] have the resources to train the ...

Girls with eating disorders regain healthy fatty acid levels when their weight normalizes

2012-07-18
A study of teenage girls with eating disorders has shown that reduced essential fatty acid levels returned to normal once the girls increased their weight to a healthy level. The research, published in the August issue of Acta Paediatrica, suggests that it is not necessary to give omega-3 polyunsaturated fatty acid supplements to adolescent girls with eating disorders. "Essential fatty acid status is altered in eating disorders that result in weight loss" explains co-author Dr Ingemar Swenne from Uppsala University Children's Hospital. "This is important because ...

Scientists find new way to induce programmed cell death, or apoptosis

2012-07-18
Researchers from the Hebrew University of Jerusalem and the Weizmann Institute of Science have developed a technique to cause apoptosis, or programmed cell death, that could lead to new approaches to treating cancer. Apoptosis is an essential defense mechanism against the spread of abnormal cells such as cancer. It is a complex process that occurs through networks of proteins that interact with each other. Cancer cells usually avoid this process due to mutations in the genes that encode the relevant proteins. The result is that the cancer cells survive and take over while ...

What it takes to be the perfect invading parasite

2012-07-18
Scientists from the Zoological Society of London (ZSL) are the first to document the characteristics of invading parasites, using malaria in New Zealand bird species. The study, published today in Ecology Letters, identifies the factors influencing the success of parasites unintentionally introduced to new environments. Avian malaria is a disease caused by species of parasites, of the genus Plasmodium, which infects birds. Just like human malaria, it is spread by mosquitoes, and the parasites spend part of their lives in red blood cells of birds. Avian malaria is common ...

In search of the key word

2012-07-18
Human beings have the ability to convert complex phenomena into a one-dimensional sequence of letters and put it down in writing. In this process, keywords serve to convey the content of the text. How letters and words correlate with the subject of a text is something Eduardo Altmann and his colleagues from the Max Planck Institute for the Physics of Complex Systems have studied with the help of statistical methods. They discovered that what denotes keywords is not the fact that they appear very frequently in a given text. It is that they are found in greater numbers only ...

Marijuana use doubles risk of premature birth

2012-07-18
A large international study led by University of Adelaide researchers has found that women who use marijuana can more than double the risk of giving birth to a baby prematurely. Preterm or premature birth - at least three weeks before a baby's due date - can result in serious and life-threatening health problems for the baby, and an increased risk of health problems in later life, such as heart disease and diabetes. A study of more than 3000 pregnant women in Adelaide, Australia and Auckland, New Zealand has detailed the most common risk factors for preterm birth. ...

Infants' recognition of speech more sophisticated than previously known, NYU researchers find

2012-07-18
The ability of infants to recognize speech is more sophisticated than previously known, researchers in New York University's Department of Psychology have found. Their study, which appears in the journal Developmental Psychology, showed that infants, as early as nine months old, could make distinctions between speech and non-speech sounds in both humans and animals. "Our results show that infant speech perception is resilient and flexible," explained Athena Vouloumanos, an assistant professor at NYU and the study's lead author. "This means that our recognition of speech ...

Marriage has different meanings for blacks and whites

2012-07-18
EAST LANSING, Mich. — Black people who are married don't appear to live any longer than black couples who simply live together, suggesting marriage doesn't boost longevity for blacks the way it does for whites, according to a large national study led by Michigan State University. "This finding implies that marriage and cohabitation have very different meanings for blacks and whites," said MSU sociologist Hui Liu, the study's lead researcher. The study, in the Journal of Marriage and Family, is the first to document mortality differences between cohabiters and married ...

Study suggests moderate drinking lowers risk of developing rheumatoid arthritis in women

2012-07-18
A follow-up study of more than 34,000 women in Sweden has shown that moderate drinkers, in comparison with abstainers, were at significantly lower risk of developing rheumatoid arthritis (RA), an often serious and disabling type of arthritis. RA is known to relate to inflammation, and it is thought that this inflammation is blocked to some degree by the consumption of alcohol. In this study, women who consumed at least 4 drinks per week (with a drink being defined as containing 15 grams of alcohol) had 37% lower risk of developing RA than subjects reporting never drinking ...

World record: Scientists from northern Germany produce the lightest material in the world

2012-07-18
A network of porous carbon tubes that is three-dimensionally interwoven at nano and micro level – this is the lightest material in the world. It weights only 0.2 milligrams per cubic centimetre, and is therefore 75 times lighter than Styrofoam, but it is very strong nevertheless. Scientists of Kiel University (KU) and Hamburg University of Technology (TUHH) have named their joint creation "Aerographite". The scientific results were published as the title story in the scientific journal Advanced Materials on July, 3rd. Today (Tuesday, July 17th) it is presented to the public. The ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] Widely prescribed MS treatment may not slow progression of disease: VCH-UBC research